Gabriel M.I. Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, Inc. (HNGE), sold 50,000 shares of Class A Common Stock on April 1, 2026, for about $1.9 million, according to a company filing.
The disposition was executed in two tranches. In the larger tranche, 49,332 shares were sold at a weighted average price with individual trade prices ranging from $37.86 to $38.85, producing a total value of $1,922,779. A separate, smaller block of 668 shares was sold at prices between $38.87 and $39.05.
On the same day as the sale, Mecklenburg converted 50,000 shares of Class B Common Stock into Class A Common Stock.
The transaction took place while Hinge Health was trading near $38.98 and with a reported enterprise value of $3.03 billion. Investors reviewing valuation metrics may note that, per InvestingPro analysis, the stock appears undervalued on a Fair Value basis. The company is also projected to move to profitability in the current year, with forecasted earnings of $2.12 per share, a considerable swing from last year’s reported loss of $7.77 per share. HNGE’s full Pro Research Report is available exclusively on InvestingPro.
Recent analyst coverage and corporate developments
Hinge Health has been the subject of multiple analyst updates and a management-related board appointment in the period surrounding the insider transaction.
- RBC Capital raised its price target for Hinge Health to $55 and kept an Outperform rating following investor meetings that emphasized growth potential in areas including AI and market expansion.
- Truist Securities reiterated a Buy rating and set a $63 price target after discussions with Hinge Health management concerning the company’s fourth-quarter 2025 performance and prospects.
- Barclays trimmed its price target to $52 while maintaining an Overweight rating, citing improved billings and engagement metrics in its analysis of the company’s fourth-quarter results.
- Jefferies initiated coverage with a Hold rating and established a $17.50 price target.
- Separately, Hinge Health appointed Tyler Sloat, currently CFO and COO of Freshworks, to its board of directors.
Collectively, these analyst actions and the board appointment reflect a mix of cautious optimism and strategic positioning as the company works through its next growth phase.
Context and what to watch
Investors looking at the insider sale will find it notable that Mecklenburg both sold a block of Class A shares and converted a separate block of Class B shares to Class A on the same calendar day. The company’s shifting earnings profile - from a loss of $7.77 per share last year to an expected earnings-per-share of $2.12 this year - is a central element of current market dialogue, as are the differing analyst valuations represented by the range of price targets.
For those seeking deeper, proprietary analysis of HNGE, the company’s Pro Research Report is offered exclusively through InvestingPro.